Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Women must fight for equal opportunities - Motshekga

2010-08-06

Photo: Stephen Collett

“We will not know peace and prosperity unless all women are free. We must open opportunities for women and make sure that we achieve the necessary progress. I believe this would be the best way to honour the life of Charlotte Maxeke.”

This rallying call for action was made by the Minister of Basic Education, Ms Angie Motshekga (pictured), in her speech to commemorate the life of Charlotte Maxeke, a woman she described as “a heroine” to all South Africans.

The University of the Free State (UFS), in conjunction with the Free State Premier’s office, presented the annual Charlotte Maxeke Memorial Lecture at the Main Campus in Bloemfontein to once again honour this remarkable African woman as part of celebrating Women’s Month.

“We must ensure that we act consciously to extend equal opportunities, freedom and justice to all women,” she said. “We must put all our energies together in this task of uplifting women and children.”

She said that even though women had made considerable strides since the advent of democracy in South Africa, especially in government, much still had to be done to ensure equal opportunities for all women.

“There’s a 40% women representation in government, but the question we should ask ourselves is: What value does this representation bring to the life of an ordinary woman? What impact does it have on her life?” she asked.

She said women were still less represented in managerial positions. “Sexism requires the same amount of energy that we use to fight against racism,” she said.

She also announced that the government had decided to declare the graves of Charlotte Maxeke, Lillian Ngoyi and Helen Joseph as national heritage sites.

The well-attended lecture was entitled: United in action to make 2010-2020 a decade for women in Africa.

Among those present were members of the ANC Women’s League, who came in buses and mini-buses; Dr Allan Boesak and his wife; past and present Free State MECs; and the Vice-Rector of External Relations at the UFS, Prof. Ezekiel Moraka.

Media Release:
Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt@ufs.ac.za
6 August 2010

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept